IMVAX, INC.

Profile

Company Names

IMVAX, INC.

Addresses

601 WALNUT STREET, SUITE 440, PHILADELPHIA, PA 19106

40 WEST EVERGREEN AVENUE, SUITE 101, PHILADELPHIA, PA 19118

Phone Numbers

215-485-0071

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$151,828,459.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2020-07-15 
$112,370,500.00 
$112,370,500.00 
$0.00 
Equity 
2
2019-05-10 
$24,763,299.00 
$25,072,980.00 
$309,681.00 
Equity 
1
2017-04-24 
$14,694,660.00 
$15,000,000.00 
$305,340.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEVEN 
 
ALTSCHULER 
DIRECTOR
WEIGHT WATCHERS INTERNATIONAL INC   |  IMVAX, INC.   |  AFFINIVAX, INC.   |  ORCHARD THERAPEUTICS PLC   |  PLATELET BIOGENESIS, INC.   |  ASCLEPIX THERAPEUTICS, INC.   |  CORNER THERAPEUTICS, INC.
DAVID 
 
ANDREWS 
EXECUTIVE OFFICER, DIRECTOR
AMERICAN STRATEGIC MINERALS CORP   |  HSCM BERMUDA FUND LTD.   |  IMVAX, INC.   |  HUDSON TRANSPORT REAL ASSET FUND LP   |  HUDSON TRANSPORT REAL ASSET (OFFSHORE) FUND LP   |  HSCM BERMUDA SPECIAL OPPORTUNITIES FUND LTD.   |  HS MARITIME CO-FUND LP   |  CONVERGE TECHNOLOGY PARTNERS INC.   |  HSCM BERMUDA ALT CAT FUND LTD.   |  HS MARITIME CO-FUND II LP   |  INTERNATIONAL LOGISTICS HOLDING, LLC
IRA 
 
BRIND 
DIRECTOR
IMVAX, INC.
DAVID 
 
BUNNING 
DIRECTOR
IMVAX, INC.   |  EVOENDO, INC.
PETER 
 
CORR 
DIRECTOR, EXECUTIVE OFFICER
IMVAX, INC.   |  LAKEWOOD-AMEDEX, INC.
WENDY 
 
DICICCO 
DIRECTOR
QUENCH USA, INC.   |  CANNAPHARMARX, INC.   |  CENTINEL SPINE, LLC   |  CARMELL THERAPEUTICS CORP   |  RENOVACOR, INC.   |  IMVAX, INC.   |  EYEPOINT PHARMACEUTICALS, INC.   |  EXPRESSCELLS, INC.   |  AKARI THERAPEUTICS PLC
JOHN 
 
FUREY 
EXECUTIVE OFFICER, DIRECTOR
IMVAX, INC.
ARTHUR 
W 
HOWE 
EXECUTIVE OFFICER, DIRECTOR
VERVE WIRELESS, INC   |  IMVAX, INC.
TED 
 
KOUTOUZIS 
DIRECTOR
NEURAL ANALYTICS, INC.   |  CALA HEALTH, INC.   |  IMVAX, INC.   |  EXO IMAGING, INC.   |  ONCORESPONSE INC   |  NOVASIGNAL CORP.   |  IMMUNOGENESIS, INC.
THOMAS 
 
PFISTERER 
DIRECTOR
IMVAX, INC.   |  SERMONIX PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-07-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-07-15 
2019-05-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-05-10 
2017-06-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-04-24 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#